Select a Meeting...

Meetings Archive For SHM Converge 2023..

Abstract Number: 144
COVID-19 ASSOCIATED MYOCARDITIS CLINICAL OUTCOMES AMONG HOSPITALIZED US PATIENTS
SHM Converge 2023
Background: Coronavirus-19 (COVID-19), primarily a respiratory virus, can affect multiple organs, including the heart. Cardiac complications can affect 20-30% of COVID-19 patients and lead to worse morbidity and mortality. Cardiovascular complications can include myocarditis, acute myocardial infarction, heart failure, and arrhythmias Myocarditis is a well-known complication among COVID-19 infections, with limited large-scale studies evaluating outcomes [...]
Abstract Number: 145
DISPARITIES IN NUMERIC PAIN VALUES AND OPIOID ADMINISTRATION IN ADULTS
SHM Converge 2023
Background: Pain is assessed by nurses through either reported or observed intensity. Self-reported assessments, specifically a numeric score, are the gold standard and preferred to behavioral assessments. Disparities in the assessment and management of pain across race, ethnicity, and language status are prevalent, but we do not know how actual numeric pain scores vary and [...]
Abstract Number: 146
DOES THE TIME FROM DISCHARGE TO READMISSION IMPACT OUTCOMES?
SHM Converge 2023
Background: In 2012, as part of Value based purchasing program, CMS instituted the Hospital Readmission Reduction program (HRRP). This aimed to decrease the number of unplanned readmission to the hospital for six conditions: Acute myocardial infarction(AMI),chronic obstructive pulmonary disease( COPD), Heart Failure (HF), Pneumonia ( PNA) , Coronary bypass graft(CABG), Elective total hip arthroplasty (THA) [...]
Abstract Number: 147
HOSPITALIZATION RATES WITH COMPREHENSIVE CARE PHYSICIANS VS. PRIMARY CARE PHYSICIANS/HOSPITALISTS
SHM Converge 2023
Background: For patients at increased risk of hospitalization, reducing hospitalization is often a key objective and can have important effects on health care costs. The Comprehensive Care Physician (CCP) model was developed originally at the University of Chicago to reintegrate inpatient and outpatient care under the same physician for patients at high risk of hospitalization [...]
Abstract Number: 148
REMDESIVIR REDUCES MORTALITY IN HOSPITALIZED COVID-19 PATIENTS REQUIRING LOW-FLOW OXYGEN
SHM Converge 2023
Background: We observed improved survival among COVID-19 patients receiving remdesivir (RDV) during the early parts of the pandemic (Aug-Nov 2020) [1]. Clinical management of COVID-19 continues to develop over time as variants of concern (VOC) evolve. We extend the previous study to characterize outcomes for patients admitted on low-flow oxygen (LFO) and compare hospital all-cause [...]
Abstract Number: 149
EFFECTS OF ANTI-DIABETES MEDICATIONS ON CLINICAL OUTCOMES OF COVID-19 PATIENTS
SHM Converge 2023
Background: The effects of diabetes medications on COVID-19 hospitalization outcomes have not been consistent. We sought to determine the effect of metformin, DPP-4 inhibitors (DPP-4i), and insulin on admission to the intensive care unit (ICU), need for assisted ventilation, development of renal insufficiency, and mortality, in patients admitted with COVID-19 infection after controlling for clinical [...]
Abstract Number: 150
HELICOBACTER PYLORI ASSOCIATED GASTRO-INTESTINAL BLEEDING IN BARIATRIC SURGERY – NATIONWIDE-SURVEY
SHM Converge 2023
Background: A higher Helicobacter pylori (H. pylori) prevalence was associated with increased rates of post-operative complications including increased marginal ulceration and leak rates. Limited studies described prevalence of H. pylori in patients undergoing bariatric surgery and H. pylori associated upper and lower gastrointestinal bleeding (GIB). Primary Aim of our study was to evaluate the prevalence [...]
Abstract Number: 151
VENTRICULAR TACHYCARDIA AND IN-HOSPITAL MORTALITY AMONG INTENSIVE CARE UNIT PATIENTS
SHM Converge 2023
Background: A priority of bedside electrocardiographic (ECG) monitoring is identification of ventricular tachycardia (VT), a lethal arrhythmia associated with morbidity and mortality. However, up to 87% of VT alarms could be false. In addition, little is known about the rate of mortality associated with VT. We assessed the rate of 30-day in-hospital mortality associated with [...]
Abstract Number: 152
USE OF CONTEMPORARY TECHNOLOGIES TO PREVENT DIABETES KETOACIDOSIS READMISSIONS
SHM Converge 2023
Background: Diabetes mellitus (DM) is a chronic disease where treatment is directed toward reducing and delaying its potentially severe short- and long-term complications. The estimated population (20-79 years old) with diabetes is 32.22 million in the United States, and 12.5% of people live with undiagnosed diabetes (Figure 1). Diabetes Mellitus is currently the most prevalent [...]
Abstract Number: 153
OUTCOMES AMONG HOSPITALIZED COVID-19 PATIENTS WITH STEMI IN THE US
SHM Converge 2023
Background: ST-segment elevation myocardial infarction (STEMI) is a cardiac emergency that requires timely reperfusion preferably with cardiac catheterization. The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2), has adversely impacted the delivery of healthcare to patients with STEMI. Several process changes were observed across the world during this period, including alternative cardiac [...]